Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

Relatively strong day, if not a blockbuster. It halted the recent weakness we've seen; Some decent buys, if not huge ones. .04 seems recapturable with stronger support next time.

Rome was not built in a day.

Actually, this was very good news today. PH-10 has shown it can accomplish what comparable medications can do, without any side effects beyond light sensitivity. At a fraction of the cost of competing drugs. So, real potential is there, even after all these years.

This may make financing a little easier (let's not forget the last round was a Hail Mary pass), which in turn will help the pps.

The new team seems to be accomplishing a lot this year. What is keeping the pps down is the uncertainty about future financing.

As the company has said before, they will let the data do the talking.

Well, ok, this time they treated themselves to a PR. But the news isn't fluff. It is what we want and need.

I feel more and more confident that there will be more positive news ahead.